{
  "params": {
    "ind": "药品及生物科技",
    "sort": "ygc",
    "page": 1,
    "q": "",
    "sig": false,
    "fcf": "",
    "screen": false,
    "big": true,
    "mine": false
  },
  "pages": 1,
  "count": 34,
  "fcf_counts": {
    "all": 34,
    "end": 11,
    "yoy": 3,
    "trend": 10
  },
  "cap_counts": {
    "all": 170,
    "big": 34
  },
  "mine_counts": {
    "all": 34,
    "mine": 0
  },
  "watch_count": 0,
  "watch_updated": null,
  "triggered": 0,
  "details_updated_bj": "2026-10-17 13:54",
  "universe_updated_bj": "2026-10-17 13:49",
  "quotes_updated_bj": "2026-10-17 14:00",
  "quote_source": "腾讯",
  "a_updated_bj": "2026-10-17 14:00",
  "hkd_cny": 0.8517,
  "ah_count": 176,
  "main_period": "2026-06-30",
  "coverage": {
    "2026-06-30": 1995,
    "2025-06-30": 47,
    "2026-03-31": 403,
    "2024-12-31": 15,
    "2026-01-31": 7,
    "2025-12-31": 26,
    "2026-04-30": 15,
    "2025-10-31": 1,
    "2026-02-28": 23,
    "2025-09-30": 4,
    "2025-03-31": 4,
    "2026-09-30": 3,
    "2026-05-31": 8
  },
  "fcf_years": [
    "2021",
    "2022",
    "2023",
    "2024",
    "2025"
  ],
  "missing": [],
  "rows": [
    {
      "code": "03320",
      "name": "华润医药",
      "l1": "药品及生物科技",
      "l2": "红筹股",
      "price": 4.605,
      "market_cap_yi": 246.4,
      "ev_yi": 995.4,
      "ee": 24,
      "loss": false,
      "ygc": 1.41,
      "triggered": false,
      "fcf_growth": [
        "end",
        "trend"
      ],
      "detail": {
        "total_liabilities_yi": 1749.92,
        "cash_yi": 156.22,
        "np_ttm_yi": 41.55,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          82.2,
          80.8,
          124.2,
          143.3,
          169.3
        ],
        "fcf_avg_yi": 119.96,
        "ibd_yi": 617.64,
        "k": 0.47,
        "k_src": "profit",
        "iv_yi": 346.9446
      },
      "revenue_ttm_yi": 2721.65,
      "net_margin": 1.5,
      "roe_by_year": {
        "2023": 8.6112,
        "2024": 7.1141,
        "2025": 8.1191
      },
      "roe_avg": 7.95,
      "common_equity_yi": 527.9645,
      "pb": 0.47,
      "roe_pb": 17.03,
      "watched": false
    },
    {
      "code": "01099",
      "name": "国药控股",
      "l1": "药品及生物科技",
      "l2": "H股",
      "price": 15.72,
      "market_cap_yi": 417.8,
      "ev_yi": 1889.8,
      "ee": 26.6,
      "loss": false,
      "ygc": 1.11,
      "triggered": false,
      "fcf_growth": [
        "end",
        "trend"
      ],
      "detail": {
        "total_liabilities_yi": 2680.87,
        "cash_yi": 310.45,
        "np_ttm_yi": 70.93,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          70.5,
          185.5,
          148.4,
          95.8,
          125.2
        ],
        "fcf_avg_yi": 125.08,
        "ibd_yi": 813.16,
        "k": 0.621,
        "k_src": "profit",
        "iv_yi": 464.56388999999996
      },
      "revenue_ttm_yi": 5719.24,
      "net_margin": 1.2,
      "roe_by_year": {
        "2023": 12.6936,
        "2024": 9.1873,
        "2025": 8.788
      },
      "roe_avg": 10.22,
      "common_equity_yi": 851.9406,
      "pb": 0.49,
      "roe_pb": 20.85,
      "watched": false
    },
    {
      "code": "01530",
      "name": "三生制药",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 14.47,
      "market_cap_yi": 309.7,
      "ev_yi": 290.9,
      "ee": 3.5,
      "loss": false,
      "ygc": 1.05,
      "triggered": false,
      "fcf_growth": [
        "end",
        "yoy",
        "trend"
      ],
      "detail": {
        "total_liabilities_yi": 48.14,
        "cash_yi": 67.85,
        "np_ttm_yi": 82.71,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          4.3,
          11.6,
          13.8,
          22.4,
          91.3
        ],
        "fcf_avg_yi": 28.679999999999996,
        "ibd_yi": 13.87,
        "k": 0.955,
        "k_src": "profit",
        "iv_yi": 325.44489999999996
      },
      "revenue_ttm_yi": 178.66,
      "net_margin": 46.3,
      "roe_by_year": {
        "2023": 11.4931,
        "2024": 14.1861,
        "2025": 39.781
      },
      "roe_avg": 21.82,
      "common_equity_yi": 275.191,
      "pb": 1.13,
      "roe_pb": 19.39,
      "watched": false
    },
    {
      "code": "01513",
      "name": "丽珠医药",
      "l1": "药品及生物科技",
      "l2": "H股",
      "price": 21.26,
      "market_cap_yi": 218.7,
      "ev_yi": 233.9,
      "ee": 14,
      "loss": false,
      "ygc": 1,
      "triggered": false,
      "fcf_growth": [
        "end",
        "trend"
      ],
      "detail": {
        "total_liabilities_yi": 89.94,
        "cash_yi": 73.51,
        "np_ttm_yi": 16.74,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          5.9,
          18.3,
          24.3,
          24.1,
          25.7
        ],
        "fcf_avg_yi": 19.66,
        "ibd_yi": 34.4,
        "k": 0.924,
        "k_src": "profit",
        "iv_yi": 217.79604
      },
      "revenue_ttm_yi": 107.48,
      "net_margin": 15.6,
      "roe_by_year": {
        "2023": 13.9954,
        "2024": 14.7723,
        "2025": 14.5816
      },
      "roe_avg": 14.45,
      "common_equity_yi": 133.6583,
      "pb": 1.64,
      "roe_pb": 8.83,
      "watched": false
    },
    {
      "code": "00867",
      "name": "康哲药业",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 10.2,
      "market_cap_yi": 211.4,
      "ev_yi": 201.6,
      "ee": 13.1,
      "loss": false,
      "ygc": 0.89,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 15.93,
        "cash_yi": 25.72,
        "np_ttm_yi": 15.34,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          23.1,
          30.3,
          21.8,
          8.1,
          2.4
        ],
        "fcf_avg_yi": 17.14,
        "ibd_yi": 8.83,
        "k": 1,
        "k_src": "profit",
        "iv_yi": 188.29
      },
      "revenue_ttm_yi": 87.11,
      "net_margin": 17.6,
      "roe_by_year": {
        "2023": 15.9482,
        "2024": 10.1772,
        "2025": 8.8343
      },
      "roe_avg": 11.65,
      "common_equity_yi": 179.4692,
      "pb": 1.18,
      "roe_pb": 9.89,
      "watched": false
    },
    {
      "code": "06618",
      "name": "京东健康",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 38.56,
      "market_cap_yi": 1047.8,
      "ev_yi": 1070.5,
      "ee": 17.2,
      "loss": false,
      "ygc": 0.68,
      "triggered": false,
      "fcf_growth": [
        "end",
        "trend"
      ],
      "detail": {
        "total_liabilities_yi": 227.15,
        "cash_yi": 204.46,
        "np_ttm_yi": 62.16,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          29.1,
          36.3,
          45.4,
          43.3,
          101.7
        ],
        "fcf_avg_yi": 51.160000000000004,
        "ibd_yi": 8.75,
        "k": 1,
        "k_src": "equity",
        "iv_yi": 707.3100000000001
      },
      "revenue_ttm_yi": 790.39,
      "net_margin": 7.9,
      "roe_by_year": {
        "2023": 4.5505,
        "2024": 7.9586,
        "2025": 9.324
      },
      "roe_avg": 7.28,
      "common_equity_yi": 614.5611,
      "pb": 1.7,
      "roe_pb": 4.27,
      "watched": false
    },
    {
      "code": "00874",
      "name": "白云山",
      "l1": "药品及生物科技",
      "l2": "H股",
      "price": 13.3,
      "market_cap_yi": 305.2,
      "ev_yi": 631.4,
      "ee": 24.6,
      "loss": false,
      "ygc": 0.66,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 463.37,
        "cash_yi": 118.88,
        "np_ttm_yi": 25.63,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          44.2,
          56.2,
          24.8,
          23.1,
          -14.7
        ],
        "fcf_avg_yi": 26.720000000000006,
        "ibd_yi": 174.54,
        "k": 0.947,
        "k_src": "profit",
        "iv_yi": 200.32838000000004
      },
      "revenue_ttm_yi": 779.13,
      "net_margin": 3.3,
      "roe_by_year": {
        "2023": 12.1093,
        "2024": 8.0072,
        "2025": 8.0961
      },
      "roe_avg": 9.4,
      "common_equity_yi": 391.3205,
      "pb": 0.78,
      "roe_pb": 12.06,
      "watched": false
    },
    {
      "code": "01093",
      "name": "石药集团",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 8.88,
      "market_cap_yi": 871.5,
      "ev_yi": 939.6,
      "ee": 12.6,
      "loss": false,
      "ygc": 0.45,
      "triggered": false,
      "fcf_growth": [
        "end"
      ],
      "detail": {
        "total_liabilities_yi": 165.9,
        "cash_yi": 96.66,
        "np_ttm_yi": 74.28,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          28.8,
          49,
          22.9,
          18.6,
          35.5
        ],
        "fcf_avg_yi": 30.959999999999997,
        "ibd_yi": 6.52,
        "k": 0.984,
        "k_src": "profit",
        "iv_yi": 393.34416
      },
      "revenue_ttm_yi": 313.27,
      "net_margin": 23.7,
      "roe_by_year": {
        "2023": 18.5276,
        "2024": 13.2219,
        "2025": 11.8641
      },
      "roe_avg": 14.54,
      "common_equity_yi": 376.2411,
      "pb": 2.32,
      "roe_pb": 6.28,
      "watched": false
    },
    {
      "code": "01177",
      "name": "中国生物制药",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 5.25,
      "market_cap_yi": 835.4,
      "ev_yi": 999.3,
      "ee": 41.8,
      "loss": false,
      "ygc": 0.36,
      "triggered": false,
      "fcf_growth": [
        "end",
        "trend"
      ],
      "detail": {
        "total_liabilities_yi": 369.63,
        "cash_yi": 121.24,
        "np_ttm_yi": 23.89,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          35,
          47.2,
          45.9,
          52.2,
          75.9
        ],
        "fcf_avg_yi": 51.24000000000001,
        "ibd_yi": 171.71,
        "k": 0.66,
        "k_src": "profit",
        "iv_yi": 304.8738000000001
      },
      "revenue_ttm_yi": 337.04,
      "net_margin": 7.1,
      "roe_by_year": {
        "2023": 7.7445,
        "2024": 11.2111,
        "2025": 7.4829
      },
      "roe_avg": 8.81,
      "common_equity_yi": 325.6808,
      "pb": 2.57,
      "roe_pb": 3.44,
      "watched": false
    },
    {
      "code": "00241",
      "name": "阿里健康",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 3.005,
      "market_cap_yi": 414,
      "ev_yi": 412,
      "ee": 21.3,
      "loss": false,
      "ygc": 0.34,
      "triggered": false,
      "fcf_growth": [
        "end",
        "trend"
      ],
      "detail": {
        "total_liabilities_yi": 52.37,
        "cash_yi": 54.34,
        "np_ttm_yi": 19.36,
        "period": "2026-03-31",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          4.1,
          2.5,
          10.6,
          13.8,
          12.3
        ],
        "fcf_avg_yi": 8.66,
        "ibd_yi": 0.6,
        "k": 1,
        "k_src": "equity",
        "iv_yi": 140.34
      },
      "revenue_ttm_yi": 342.55,
      "net_margin": 5.7,
      "roe_by_year": {
        "2023": 5.9458,
        "2024": 9.2845,
        "2025": 11.3333
      },
      "roe_avg": 8.85,
      "common_equity_yi": 178.554,
      "pb": 2.32,
      "roe_pb": 3.82,
      "watched": false
    },
    {
      "code": "01276",
      "name": "恒瑞医药",
      "l1": "药品及生物科技",
      "l2": "H股",
      "price": 47.6,
      "market_cap_yi": 3079.2,
      "ev_yi": 2756.7,
      "ee": 35.7,
      "loss": false,
      "ygc": 0.28,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 57.83,
        "cash_yi": 380.32,
        "np_ttm_yi": 77.26,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          null,
          -7.3,
          61.6,
          54.5,
          82.7
        ],
        "fcf_avg_yi": 47.875,
        "ibd_yi": 0.68,
        "k": 1,
        "k_src": "profit",
        "iv_yi": 858.39
      },
      "revenue_ttm_yi": 313.24,
      "net_margin": 24.7,
      "roe_by_year": {
        "2023": 10.9911,
        "2024": 14.7386,
        "2025": 14.4413
      },
      "roe_avg": 13.39,
      "common_equity_yi": 644.6643,
      "pb": 4.78,
      "roe_pb": 2.8,
      "watched": false
    },
    {
      "code": "03692",
      "name": "翰森制药",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 31.74,
      "market_cap_yi": 1639.3,
      "ev_yi": 1681.1,
      "ee": 25.2,
      "loss": false,
      "ygc": 0.21,
      "triggered": false,
      "fcf_growth": [
        "end",
        "yoy",
        "trend"
      ],
      "detail": {
        "total_liabilities_yi": 88.37,
        "cash_yi": 46.57,
        "np_ttm_yi": 66.78,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          21,
          24.5,
          27.5,
          33.4,
          62.5
        ],
        "fcf_avg_yi": 33.78,
        "ibd_yi": 42.34,
        "k": 1,
        "k_src": "profit",
        "iv_yi": 342.03000000000003
      },
      "revenue_ttm_yi": 158.99,
      "net_margin": 42,
      "roe_by_year": {
        "2023": 13.5317,
        "2024": 16.0508,
        "2025": 17.3488
      },
      "roe_avg": 15.64,
      "common_equity_yi": 377.6807,
      "pb": 4.34,
      "roe_pb": 3.6,
      "watched": false
    },
    {
      "code": "02096",
      "name": "先声药业",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 11.02,
      "market_cap_yi": 241,
      "ev_yi": 270,
      "ee": 17.2,
      "loss": false,
      "ygc": 0.18,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 59.74,
        "cash_yi": 30.72,
        "np_ttm_yi": 15.72,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          -4.1,
          6.8,
          -8.3,
          6.2,
          11.5
        ],
        "fcf_avg_yi": 2.42,
        "ibd_yi": 11.72,
        "k": 1,
        "k_src": "profit",
        "iv_yi": 43.199999999999996
      },
      "revenue_ttm_yi": 87.27,
      "net_margin": 18,
      "roe_by_year": {
        "2023": 9.9587,
        "2024": 10.2606,
        "2025": 16.2499
      },
      "roe_avg": 12.16,
      "common_equity_yi": 94.2425,
      "pb": 2.56,
      "roe_pb": 4.75,
      "watched": false
    },
    {
      "code": "03347",
      "name": "泰格医药",
      "l1": "药品及生物科技",
      "l2": "H股",
      "price": 40.2,
      "market_cap_yi": 411.6,
      "ev_yi": 436.5,
      "ee": 479.7,
      "loss": false,
      "ygc": 0.17,
      "triggered": false,
      "fcf_growth": [
        "end",
        "trend"
      ],
      "detail": {
        "total_liabilities_yi": 48.02,
        "cash_yi": 20.43,
        "np_ttm_yi": 0.91,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          7.9,
          6.8,
          8.4,
          7.4,
          9
        ],
        "fcf_avg_yi": 7.9,
        "ibd_yi": 20.91,
        "k": 0.904,
        "k_src": "profit",
        "iv_yi": 70.98208000000001
      },
      "revenue_ttm_yi": 72.9,
      "net_margin": 1.2,
      "roe_by_year": {
        "2023": 9.9589,
        "2024": 1.9433,
        "2025": 4.2656
      },
      "roe_avg": 5.39,
      "common_equity_yi": 194.7722,
      "pb": 2.11,
      "roe_pb": 2.55,
      "watched": false
    },
    {
      "code": "06821",
      "name": "凯莱英",
      "l1": "药品及生物科技",
      "l2": "H股",
      "price": 137.6,
      "market_cap_yi": 530.8,
      "ev_yi": 524.7,
      "ee": 50.6,
      "loss": false,
      "ygc": 0.14,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 30.86,
        "cash_yi": 37,
        "np_ttm_yi": 10.36,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          -15.5,
          11.4,
          23.1,
          1.2,
          1.4
        ],
        "fcf_avg_yi": 4.319999999999999,
        "ibd_yi": 3.47,
        "k": 1,
        "k_src": "profit",
        "iv_yi": 76.72999999999999
      },
      "revenue_ttm_yi": 70.89,
      "net_margin": 14.6,
      "roe_by_year": {
        "2023": 13.6976,
        "2024": 5.5292,
        "2025": 6.5693
      },
      "roe_avg": 8.6,
      "common_equity_yi": 177.3987,
      "pb": 2.99,
      "roe_pb": 2.87,
      "watched": false
    },
    {
      "code": "02359",
      "name": "药明康德",
      "l1": "药品及生物科技",
      "l2": "H股",
      "price": 196.2,
      "market_cap_yi": 4473.8,
      "ev_yi": 4527.5,
      "ee": 20.6,
      "loss": false,
      "ygc": 0.13,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 323.79,
        "cash_yi": 269.54,
        "np_ttm_yi": 219.88,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          -32.6,
          2.7,
          71.3,
          79.9,
          108.9
        ],
        "fcf_avg_yi": 46.04,
        "ibd_yi": 151.12,
        "k": 0.99,
        "k_src": "profit",
        "iv_yi": 573.0318
      },
      "revenue_ttm_yi": 527.93,
      "net_margin": 41.6,
      "roe_by_year": {
        "2023": 21.0204,
        "2024": 16.4434,
        "2025": 27.7494
      },
      "roe_avg": 21.74,
      "common_equity_yi": 833.3372,
      "pb": 5.37,
      "roe_pb": 4.05,
      "watched": false
    },
    {
      "code": "02607",
      "name": "上海医药",
      "l1": "药品及生物科技",
      "l2": "H股",
      "price": 11.17,
      "market_cap_yi": 550.7,
      "ev_yi": 1467,
      "ee": 30.8,
      "loss": false,
      "ygc": 0.09,
      "triggered": false,
      "fcf_growth": [
        "end",
        "yoy",
        "trend"
      ],
      "detail": {
        "total_liabilities_yi": 1479.84,
        "cash_yi": 322.84,
        "np_ttm_yi": 47.7,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          9.4,
          20.6,
          22.6,
          34.3,
          38.3
        ],
        "fcf_avg_yi": 25.04,
        "ibd_yi": 512.79,
        "k": 0.792,
        "k_src": "profit",
        "iv_yi": 47.8764
      },
      "revenue_ttm_yi": 2894.57,
      "net_margin": 1.6,
      "roe_by_year": {
        "2023": 5.558,
        "2024": 6.4943,
        "2025": 7.7586
      },
      "roe_avg": 6.6,
      "common_equity_yi": 783.4796,
      "pb": 0.7,
      "roe_pb": 9.39,
      "watched": false
    },
    {
      "code": "02269",
      "name": "药明生物",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 48.2,
      "market_cap_yi": 1690,
      "ev_yi": 1707.3,
      "ee": 34.1,
      "loss": false,
      "ygc": 0.04,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 108.42,
        "cash_yi": 89.5,
        "np_ttm_yi": 50.09,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          -30.9,
          -3.3,
          4.4,
          12.9,
          26.1
        ],
        "fcf_avg_yi": 1.8400000000000005,
        "ibd_yi": 27.26,
        "k": 0.914,
        "k_src": "profit",
        "iv_yi": 73.70496
      },
      "revenue_ttm_yi": 236.24,
      "net_margin": 21.2,
      "roe_by_year": {
        "2023": 9.0204,
        "2024": 8.1705,
        "2025": 11.0216
      },
      "roe_avg": 9.4,
      "common_equity_yi": 480.7044,
      "pb": 3.52,
      "roe_pb": 2.67,
      "watched": false
    },
    {
      "code": "01801",
      "name": "信达生物",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 89.05,
      "market_cap_yi": 1324.9,
      "ev_yi": 1488.4,
      "ee": 120.8,
      "loss": false,
      "ygc": 0.02,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 208.71,
        "cash_yi": 45.24,
        "np_ttm_yi": 12.32,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          -38.7,
          -33,
          -12.4,
          -4.2,
          93.2
        ],
        "fcf_avg_yi": 0.9799999999999983,
        "ibd_yi": 23.23,
        "k": 1,
        "k_src": "equity",
        "iv_yi": 31.809999999999985
      },
      "revenue_ttm_yi": 157.06,
      "net_margin": 7.8,
      "roe_by_year": {
        "2023": -8.8394,
        "2024": -0.738,
        "2025": 5.0106
      },
      "roe_avg": -1.52,
      "common_equity_yi": 207.4584,
      "pb": 6.39,
      "roe_pb": -0.24,
      "watched": false
    },
    {
      "code": "02268",
      "name": "药明合联",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 74.45,
      "market_cap_yi": 805.6,
      "ev_yi": 829.2,
      "ee": 53.4,
      "loss": false,
      "ygc": 0,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 39.54,
        "cash_yi": 15.97,
        "np_ttm_yi": 15.54,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          0.1,
          0.5,
          -2.1,
          -7.9,
          5.2
        ],
        "fcf_avg_yi": -0.8400000000000001,
        "ibd_yi": 5.32,
        "k": 1,
        "k_src": "profit",
        "iv_yi": 2.25
      },
      "revenue_ttm_yi": 69.45,
      "net_margin": 22.4,
      "roe_by_year": {
        "2023": 8.1769,
        "2024": 17.6888,
        "2025": 17.0515
      },
      "roe_avg": 14.31,
      "common_equity_yi": 112.9813,
      "pb": 7.13,
      "roe_pb": 2.01,
      "watched": false
    },
    {
      "code": "06990",
      "name": "科伦博泰生物",
      "l1": "药品及生物科技",
      "l2": "H股",
      "price": 452,
      "market_cap_yi": 920.2,
      "ev_yi": 902.3,
      "ee": 597.5,
      "loss": false,
      "ygc": -0.01,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 9.85,
        "cash_yi": 27.76,
        "np_ttm_yi": 1.51,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          -5.8,
          -3,
          -0.2,
          -5.1,
          -3.1
        ],
        "fcf_avg_yi": -3.44,
        "ibd_yi": 0.81,
        "k": 1,
        "k_src": "equity",
        "iv_yi": -7.449999999999999
      },
      "revenue_ttm_yi": 20.86,
      "net_margin": 7.2,
      "roe_by_year": {
        "2023": 128.0564,
        "2024": -9.4629,
        "2025": -9.344
      },
      "roe_avg": 36.42,
      "common_equity_yi": 53.3685,
      "pb": 17.24,
      "roe_pb": 2.11,
      "watched": false
    },
    {
      "code": "02315",
      "name": "百奥赛图-B",
      "l1": "药品及生物科技",
      "l2": "H股",
      "price": 49.16,
      "market_cap_yi": 335.4,
      "ev_yi": 339.7,
      "ee": 92.8,
      "loss": false,
      "ygc": -0.05,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 12.16,
        "cash_yi": 7.9,
        "np_ttm_yi": 3.66,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          -5.6,
          -5.4,
          -2,
          1.7,
          2.8
        ],
        "fcf_avg_yi": -1.7,
        "ibd_yi": 6.93,
        "k": 0.998,
        "k_src": "equity",
        "iv_yi": -15.997940000000002
      },
      "revenue_ttm_yi": 16.99,
      "net_margin": 21.5,
      "roe_by_year": {
        "2023": -39.6399,
        "2024": 4.1411,
        "2025": 11.5122
      },
      "roe_avg": -8,
      "common_equity_yi": 24.2163,
      "pb": 13.85,
      "roe_pb": -0.58,
      "watched": false
    },
    {
      "code": "09969",
      "name": "诺诚健华",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 12.32,
      "market_cap_yi": 227.9,
      "ev_yi": 214.8,
      "ee": 23.4,
      "loss": false,
      "ygc": -0.07,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 35.31,
        "cash_yi": 48.44,
        "np_ttm_yi": 9.19,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          0,
          -9.4,
          -9.3,
          -4.4,
          0.1
        ],
        "fcf_avg_yi": -4.6,
        "ibd_yi": 19.01,
        "k": 0.998,
        "k_src": "equity",
        "iv_yi": -16.536860000000008
      },
      "revenue_ttm_yi": 27.81,
      "net_margin": 33,
      "roe_by_year": {
        "2023": -8.5624,
        "2024": -6.3523,
        "2025": 8.891
      },
      "roe_avg": -2.01,
      "common_equity_yi": 76.7102,
      "pb": 2.97,
      "roe_pb": -0.68,
      "watched": false
    },
    {
      "code": "03759",
      "name": "康龙化成",
      "l1": "药品及生物科技",
      "l2": "H股",
      "price": 26.4,
      "market_cap_yi": 618.1,
      "ev_yi": 718.2,
      "ee": 41.9,
      "loss": false,
      "ygc": -0.08,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 118.96,
        "cash_yi": 14.57,
        "np_ttm_yi": 17.13,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          -0.3,
          -8.1,
          -1.1,
          5.4,
          5.5
        ],
        "fcf_avg_yi": 0.2800000000000001,
        "ibd_yi": 69.54,
        "k": 0.959,
        "k_src": "equity",
        "iv_yi": -50.03103000000001
      },
      "revenue_ttm_yi": 152.5,
      "net_margin": 11.2,
      "roe_by_year": {
        "2023": 13.8591,
        "2024": 13.7022,
        "2025": 11.6018
      },
      "roe_avg": 13.05,
      "common_equity_yi": 163.4877,
      "pb": 3.78,
      "roe_pb": 3.45,
      "watched": false
    },
    {
      "code": "01548",
      "name": "金斯瑞生物-一千",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 33.3,
      "market_cap_yi": 647.7,
      "ev_yi": 695.2,
      "ee": null,
      "loss": true,
      "ygc": -0.19,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 60.91,
        "cash_yi": 13.37,
        "np_ttm_yi": -44.44,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          -17.4,
          -22.6,
          -31.5,
          -5.2,
          17
        ],
        "fcf_avg_yi": -11.940000000000001,
        "ibd_yi": 17.26,
        "k": 0.999,
        "k_src": "equity",
        "iv_yi": -123.16671
      },
      "revenue_ttm_yi": 57.84,
      "net_margin": -76.8,
      "roe_by_year": {
        "2023": -7.951,
        "2024": 103.7026,
        "2025": -12.8695
      },
      "roe_avg": 27.63,
      "common_equity_yi": 264.7817,
      "pb": 2.45,
      "roe_pb": 11.29,
      "watched": false
    },
    {
      "code": "09926",
      "name": "康方生物",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 91.3,
      "market_cap_yi": 731.8,
      "ev_yi": 799.8,
      "ee": null,
      "loss": true,
      "ygc": -0.19,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 78.57,
        "cash_yi": 10.54,
        "np_ttm_yi": -9.67,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          -17.2,
          -20.4,
          15.9,
          -11.2,
          -17.3
        ],
        "fcf_avg_yi": -10.039999999999997,
        "ibd_yi": 49.85,
        "k": 1,
        "k_src": "equity",
        "iv_yi": -139.70999999999998
      },
      "revenue_ttm_yi": 34.5,
      "net_margin": -28,
      "roe_by_year": {
        "2023": 55.3578,
        "2024": -8.9432,
        "2025": -14.034
      },
      "roe_avg": 10.79,
      "common_equity_yi": 84.8645,
      "pb": 8.62,
      "roe_pb": 1.25,
      "watched": false
    },
    {
      "code": "02696",
      "name": "复宏汉霖",
      "l1": "药品及生物科技",
      "l2": "H股",
      "price": 51.35,
      "market_cap_yi": 238.5,
      "ev_yi": 319.7,
      "ee": 36.9,
      "loss": false,
      "ygc": -0.22,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 85.58,
        "cash_yi": 4.35,
        "np_ttm_yi": 8.67,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          -10.4,
          -3.8,
          0.4,
          4,
          1.1
        ],
        "fcf_avg_yi": -1.7399999999999998,
        "ibd_yi": 39.49,
        "k": 1,
        "k_src": "equity",
        "iv_yi": -52.54
      },
      "revenue_ttm_yi": 74.35,
      "net_margin": 11.7,
      "roe_by_year": {
        "2023": 28.5229,
        "2024": 31.5206,
        "2025": 23.7176
      },
      "roe_avg": 27.92,
      "common_equity_yi": 45.385,
      "pb": 5.26,
      "roe_pb": 5.31,
      "watched": false
    },
    {
      "code": "06160",
      "name": "百济神州",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 225,
      "market_cap_yi": 3029.6,
      "ev_yi": 2942.5,
      "ee": 65.5,
      "loss": false,
      "ygc": -0.23,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 272.55,
        "cash_yi": 359.66,
        "np_ttm_yi": 44.95,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          -242.6,
          -138.1,
          -125.3,
          -49.5,
          59.7
        ],
        "fcf_avg_yi": -99.16,
        "ibd_yi": 77.86,
        "k": 1,
        "k_src": "equity",
        "iv_yi": -709.7999999999997
      },
      "revenue_ttm_yi": 420.62,
      "net_margin": 10.7,
      "roe_by_year": {
        "2023": -22.2634,
        "2024": -18.7723,
        "2025": 7.4592
      },
      "roe_avg": -11.19,
      "common_equity_yi": 352.3958,
      "pb": 8.6,
      "roe_pb": -1.3,
      "watched": false
    },
    {
      "code": "09995",
      "name": "荣昌生物",
      "l1": "药品及生物科技",
      "l2": "H股",
      "price": 65.9,
      "market_cap_yi": 473,
      "ev_yi": 473,
      "ee": 8.1,
      "loss": false,
      "ygc": -0.24,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 15.33,
        "cash_yi": 15.29,
        "np_ttm_yi": 58.22,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          -3.5,
          -20.2,
          -23.5,
          -14.4,
          -1.5
        ],
        "fcf_avg_yi": -12.620000000000001,
        "ibd_yi": 3.11,
        "k": 1,
        "k_src": "equity",
        "iv_yi": -114.02000000000004
      },
      "revenue_ttm_yi": 80,
      "net_margin": 72.8,
      "roe_by_year": {
        "2023": -35.9065,
        "2024": -54.1484,
        "2025": 25.3672
      },
      "roe_avg": -21.56,
      "common_equity_yi": 83.1408,
      "pb": 5.69,
      "roe_pb": -3.79,
      "watched": false
    },
    {
      "code": "02228",
      "name": "晶泰控股",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 5.92,
      "market_cap_yi": 216.9,
      "ev_yi": 226.1,
      "ee": null,
      "loss": true,
      "ygc": -0.25,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 35.51,
        "cash_yi": 26.23,
        "np_ttm_yi": -2.11,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          -4.2,
          -6.3,
          -7,
          -5.4,
          -2.5
        ],
        "fcf_avg_yi": -5.08,
        "ibd_yi": 31.18,
        "k": 0.992,
        "k_src": "equity",
        "iv_yi": -55.30399999999999
      },
      "revenue_ttm_yi": 6.79,
      "net_margin": -31.1,
      "roe_by_year": {
        "2023": 30.3989,
        "2024": 91.8138,
        "2025": 1.8542
      },
      "roe_avg": 41.36,
      "common_equity_yi": 90,
      "pb": 2.41,
      "roe_pb": 17.16,
      "watched": false
    },
    {
      "code": "02162",
      "name": "康诺亚-B",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 81.95,
      "market_cap_yi": 208.5,
      "ev_yi": 201.7,
      "ee": 26.1,
      "loss": false,
      "ygc": -0.36,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 16.63,
        "cash_yi": 23.39,
        "np_ttm_yi": 7.74,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          -5.7,
          -13.1,
          -6.9,
          -10,
          -10.5
        ],
        "fcf_avg_yi": -9.24,
        "ibd_yi": 6.97,
        "k": 1,
        "k_src": "equity",
        "iv_yi": -75.98
      },
      "revenue_ttm_yi": 8.35,
      "net_margin": 92.7,
      "roe_by_year": {
        "2023": -11.3602,
        "2024": -18.8702,
        "2025": -19.9146
      },
      "roe_avg": -16.71,
      "common_equity_yi": 40.0573,
      "pb": 5.21,
      "roe_pb": -3.21,
      "watched": false
    },
    {
      "code": "06127",
      "name": "昭衍新药",
      "l1": "药品及生物科技",
      "l2": "H股",
      "price": 27.44,
      "market_cap_yi": 334.9,
      "ev_yi": 345.2,
      "ee": 35.1,
      "loss": false,
      "ygc": -0.36,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 18.51,
        "cash_yi": 8.24,
        "np_ttm_yi": 9.84,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          -20.7,
          0.5,
          -1.3,
          -26.9,
          -15.8
        ],
        "fcf_avg_yi": -12.84,
        "ibd_yi": 0.32,
        "k": 1,
        "k_src": "profit",
        "iv_yi": -120.48
      },
      "revenue_ttm_yi": 16.93,
      "net_margin": 58.1,
      "roe_by_year": {
        "2023": 4.8228,
        "2024": 0.9057,
        "2025": 3.6314
      },
      "roe_avg": 3.12,
      "common_equity_yi": 89.7497,
      "pb": 3.73,
      "roe_pb": 0.84,
      "watched": false
    },
    {
      "code": "02196",
      "name": "复星医药",
      "l1": "药品及生物科技",
      "l2": "H股",
      "price": 17.11,
      "market_cap_yi": 564,
      "ev_yi": 1020,
      "ee": 30.1,
      "loss": false,
      "ygc": -0.57,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 620.26,
        "cash_yi": 94.87,
        "np_ttm_yi": 33.9,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          -10.3,
          -16.7,
          -19.2,
          0.7,
          7.6
        ],
        "fcf_avg_yi": -7.58,
        "ibd_yi": 390.32,
        "k": 0.868,
        "k_src": "profit",
        "iv_yi": -322.245
      },
      "revenue_ttm_yi": 424.49,
      "net_margin": 8,
      "roe_by_year": {
        "2023": 5.3197,
        "2024": 5.9651,
        "2025": 7.0274
      },
      "roe_avg": 6.1,
      "common_equity_yi": 486.9282,
      "pb": 1.16,
      "roe_pb": 5.27,
      "watched": false
    },
    {
      "code": "01877",
      "name": "君实生物",
      "l1": "药品及生物科技",
      "l2": "H股",
      "price": 16.31,
      "market_cap_yi": 265.8,
      "ev_yi": 317.4,
      "ee": null,
      "loss": true,
      "ygc": -0.83,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 80.5,
        "cash_yi": 27.06,
        "np_ttm_yi": -4.02,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          -14.1,
          -21.6,
          -28.5,
          -21.3,
          -12.8
        ],
        "fcf_avg_yi": -19.66,
        "ibd_yi": 59.14,
        "k": 0.966,
        "k_src": "equity",
        "iv_yi": -220.90488
      },
      "revenue_ttm_yi": 30.26,
      "net_margin": -13.3,
      "roe_by_year": {
        "2023": -27.3703,
        "2024": -19.6546,
        "2025": -14.1026
      },
      "roe_avg": -20.38,
      "common_equity_yi": 59.5966,
      "pb": 4.46,
      "roe_pb": -4.57,
      "watched": false
    }
  ]
}